Olivier Gouedard Email & Phone

Chief Operating Officer @ Cytovia Therapeutics

Vice President, Global Cell Therapy Franchise, Ide-cel Program Lead (Multiple Myeloma) @ Bristol-Myers Squibb

Vice President, Global Program Leadership, Cell Therapy @ Celgene

Executive Director, Global Project Leadership, Late Stage Development @ Celgene

Executive Director, Global Project Leadership, Early Stage Development @ Celgene

Executive Director, Global Project Leadership, Hematology and Oncology and Immunology and Inflammation @ Celgene

Senior Marketing Manager, Strategic Planning and Operations, Nephrology Business Unit @ Amgen

Senior Project Manager - Program Management Strategy and Operations (Nephrology) @ Amgen

Licensing Finance Manager @ Amgen

Business Development and Alliance Manager @ Fournier Pharma

2001 - 2003 Master of Business Administration - MBA @ NYU Stern School of Business

- Master of Healthcare Management @ ESCP Business School

- Advanced Degree in Experimental and Clinical Pharmacology @ Paris-Sud University (Paris XI)

- Doctorate in Pharmacy (PharmD) @ Université de Rennes I

Leadership, Product Marketing, Management, Forecasting, Project Management, Biotechnology, Pharmaceutical Industry, Business Development, Program Management, Oncology, Cross Functional Team Leadership, Clinical Development, Strategic Alliances, Drug Development, Mergers, Strategic Planning, Strategy

Olivier Gouedard, based in Summit, NJ, US, is currently a Chief Operating Officer at Cytovia Therapeutics. Olivier Gouedard brings experience from previous roles at Bristol-Myers Squibb, Celgene, Celgene, Celgene, Celgene, Amgen, Amgen, Amgen, Fournier Pharma. Olivier Gouedard holds various educational qualifications including Master of Business Administration - MBA in Finance & Accounting (2001 - 2003) from NYU Stern School of Business. With a robust skill set that includes Leadership, Product Marketing, Management, Forecasting, Project Management, Olivier Gouedard demonstrates proficiency in a wide range of areas.